Molecular studies reveal that approximately 30% of CRC cases are associated with the serrated pathway, with characteristics of BRAF mutations, microsatellite instability (MSI), and CpG island methylator phenotype (CIMP) (4). This evidence concerns the gene BRAF and colorectal carcinoma.